Adc Therapeutics Sa Stock Market Value
| ADCT Stock | USD 1.60 0.01 0.62% |
| Symbol | ADC |
ADC Therapeutics Price To Book Ratio
Is Communications Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADC Therapeutics. If investors know ADC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.39) | Revenue Per Share | Quarterly Revenue Growth 0.274 | Return On Assets | Return On Equity |
The market value of ADC Therapeutics is measured differently than its book value, which is the value of ADC that is recorded on the company's balance sheet. Investors also form their own opinion of ADC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ADC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADC Therapeutics' market value can be influenced by many factors that don't directly affect ADC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ADC Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ADC Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ADC Therapeutics.
| 02/28/2023 |
| 02/17/2025 |
If you would invest 0.00 in ADC Therapeutics on February 28, 2023 and sell it all today you would earn a total of 0.00 from holding ADC Therapeutics SA or generate 0.0% return on investment in ADC Therapeutics over 720 days. ADC Therapeutics is related to or competes with Passage Bio, Black Diamond, Alector, Century Therapeutics, Generation Bio, Stoke Therapeutics, and Ultragenyx. ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates for patients suffering ... More
ADC Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ADC Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ADC Therapeutics SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 99.23 | |||
| Value At Risk | (10.46) | |||
| Potential Upside | 8.78 |
ADC Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ADC Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ADC Therapeutics' standard deviation. In reality, there are many statistical measures that can use ADC Therapeutics historical prices to predict the future ADC Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (3.16) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ADC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ADC Therapeutics Backtested Returns
Currently, ADC Therapeutics SA is dangerous. ADC Therapeutics retains Efficiency (Sharpe Ratio) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for ADC Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm ADC Therapeutics' variance of 110.64, and Market Risk Adjusted Performance of (3.15) to double-check if the risk estimate we provide is consistent with the expected return of 0.0973%. The firm owns a Beta (Systematic Risk) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ADC Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding ADC Therapeutics is expected to be smaller as well. ADC Therapeutics at this moment owns a risk of 10.74%. Please confirm ADC Therapeutics SA potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if ADC Therapeutics SA will be following its current price history.
Auto-correlation | 0.00 |
No correlation between past and present
ADC Therapeutics SA has no correlation between past and present. Overlapping area represents the amount of predictability between ADC Therapeutics time series from 28th of February 2023 to 23rd of February 2024 and 23rd of February 2024 to 17th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ADC Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current ADC Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.96 |
ADC Therapeutics lagged returns against current returns
Autocorrelation, which is ADC Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ADC Therapeutics' stock expected returns. We can calculate the autocorrelation of ADC Therapeutics returns to help us make a trade decision. For example, suppose you find that ADC Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ADC Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ADC Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ADC Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ADC Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
ADC Therapeutics Lagged Returns
When evaluating ADC Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ADC Therapeutics stock have on its future price. ADC Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ADC Therapeutics autocorrelation shows the relationship between ADC Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in ADC Therapeutics SA.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ADC Stock Analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.